Compare SXC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SXC | YDES |
|---|---|---|
| Founded | 1960 | 2013 |
| Country | United States | Taiwan |
| Employees | 2477 | N/A |
| Industry | Steel/Iron Ore | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 543.0M |
| IPO Year | 2011 | N/A |
| Metric | SXC | YDES |
|---|---|---|
| Price | $6.54 | $6.98 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 19.2K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $5.40 |
| 52 Week High | $9.82 | $25.00 |
| Indicator | SXC | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 45.61 |
| Support Level | $6.24 | N/A |
| Resistance Level | $6.90 | $9.11 |
| Average True Range (ATR) | 0.28 | 0.87 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 79.02 | 60.24 |
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.